TY - JOUR
T1 - Interleukin-10-1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection
AU - Persico, Marcello
AU - Capasso, Mario
AU - Persico, Eliana
AU - Masarone, Mario
AU - Renzo, Amalia de
AU - Spano, Daniela
AU - Bruno, Savino
AU - Iolascon, Achille
PY - 2006/12
Y1 - 2006/12
N2 - Background/Aims: In this study, we determined the genotypic and allelic frequencies of the Interleukin (IL)-10-1082G/A IL-10-592A/C, and IL-10-819C/T polymorphisms, and their association with the risk to develop B cell Non Hodgkin Lymphoma (NHL) in hepatitis virus C (HCV) carriers. Results: Genetic polymorphisms in the IL-10 gene promoter were studied in 250 consecutive patients with B-cell NHL with no clinical and/or laboratory findings of cryoglobulinemia, 142 NHL/HCV- and 108 NHL/HCV+ with chronic hepatitis (CH), 120 consecutive subjects with HCV-related CH, and 110 age, sex-matched healthy blood donors. The frequency of the IL-10-1082GG genotype vs remaining genotypes (IL-10-1082GA/AA) was higher in NHL/HCV+ patients than HCV-related CH patients (P = 0.0002, OR = 2.89, CI: 1.62-5.15) and in NHL/HCV+ than NHL/HCV- patients (P = 0.0001, OR = 2.99, CI: 1.72-5.19). Moreover, the IL-10-1082GG genotype was more prevalent in indolent NHL/HCV+ cases than aggressive NHL/HCV+ (P = 0.0004, OR = 4.97, CI: 2.10-11.79). Finally, we confirmed that IL-10-1082GG genotype is associated with higher IL-10 production compared to AA homozygous (P = 0.037). Conclusions: The high IL-10 production, due to IL-10-1082GG genotype, influences the clinical expression of the HCV infection by increasing susceptibility to develop NHL and might contribute to the indolent form of the disease.
AB - Background/Aims: In this study, we determined the genotypic and allelic frequencies of the Interleukin (IL)-10-1082G/A IL-10-592A/C, and IL-10-819C/T polymorphisms, and their association with the risk to develop B cell Non Hodgkin Lymphoma (NHL) in hepatitis virus C (HCV) carriers. Results: Genetic polymorphisms in the IL-10 gene promoter were studied in 250 consecutive patients with B-cell NHL with no clinical and/or laboratory findings of cryoglobulinemia, 142 NHL/HCV- and 108 NHL/HCV+ with chronic hepatitis (CH), 120 consecutive subjects with HCV-related CH, and 110 age, sex-matched healthy blood donors. The frequency of the IL-10-1082GG genotype vs remaining genotypes (IL-10-1082GA/AA) was higher in NHL/HCV+ patients than HCV-related CH patients (P = 0.0002, OR = 2.89, CI: 1.62-5.15) and in NHL/HCV+ than NHL/HCV- patients (P = 0.0001, OR = 2.99, CI: 1.72-5.19). Moreover, the IL-10-1082GG genotype was more prevalent in indolent NHL/HCV+ cases than aggressive NHL/HCV+ (P = 0.0004, OR = 4.97, CI: 2.10-11.79). Finally, we confirmed that IL-10-1082GG genotype is associated with higher IL-10 production compared to AA homozygous (P = 0.037). Conclusions: The high IL-10 production, due to IL-10-1082GG genotype, influences the clinical expression of the HCV infection by increasing susceptibility to develop NHL and might contribute to the indolent form of the disease.
KW - Hepatitis C virus
KW - Interleukin 10 genetic polymorphism
KW - Liver disease
KW - Non Hodgkin Lymphoma
UR - http://www.scopus.com/inward/record.url?scp=33750491102&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33750491102&partnerID=8YFLogxK
U2 - 10.1016/j.jhep.2006.07.026
DO - 10.1016/j.jhep.2006.07.026
M3 - Article
C2 - 17049666
AN - SCOPUS:33750491102
VL - 45
SP - 779
EP - 785
JO - Journal of Hepatology
JF - Journal of Hepatology
SN - 0168-8278
IS - 6
ER -